RVMD
Revolution Medicines, Inc.
Company overview
- Market capitalization
- $43.24B
- Employees
- 883
- Latest publication
- 2026-09-29
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -505,132,000USD | -445,222,000USD | -361,626,000USD | -315,269,000USD | -264,714,000USD | -240,760,000USD | -216,310,000USD | -156,643,000USD |
| Net Income | -644,371,000USD | -453,816,000USD | -364,892,000USD | -305,206,000USD | -247,787,000USD | -213,416,000USD | -194,569,000USD | -133,233,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 261,592,000USD | 0USD |
| Cost Of Revenue | — | 4,535,000USD | 4,702,000USD | — | 3,802,000USD | 205,749,000USD | 188,096,000USD | 12,775,000USD |
| Gross Profit | — | -4,535,000USD | -4,702,000USD | — | -3,802,000USD | -205,749,000USD | -188,096,000USD | -12,775,000USD |
| Research Development | — | 343,970,000USD | 292,607,000USD | 262,506,000USD | 224,134,000USD | 205,749,000USD | 188,096,000USD | 134,932,000USD |
| Selling General Administrative | — | 101,252,000USD | 64,316,999USD | 52,763,000USD | 40,580,000USD | 35,011,000USD | 28,214,000USD | 21,711,000USD |
| Unclassified Operating Expenses | — | -4,535,000USD | — | — | — | — | — | — |
| Total Operating Expenses | — | 440,687,000USD | 356,924,000USD | 315,269,000USD | 264,714,000USD | 240,760,000USD | 216,310,000USD | 156,643,000USD |
| Interest Income | — | 19,508,000USD | 21,292,000USD | 22,083,000USD | 22,404,000USD | 24,915,000USD | 21,225,000USD | 21,487,000USD |
| Interest Expense | — | 12,197,000USD | 11,936,000USD | 11,428,000USD | 899,000USD | — | — | — |
| Net Interest Income | — | 7,311,000USD | 9,356,000USD | 10,655,000USD | 22,404,000USD | 24,915,000USD | 21,225,000USD | 21,487,000USD |
| Income Before Tax | — | -453,816,000USD | -364,892,000USD | -305,206,000USD | -247,787,000USD | -213,416,000USD | -195,322,000USD | -133,233,000USD |
| Net Income From Continuing Ops | — | -453,816,000USD | -364,892,000USD | -305,206,000USD | -247,787,000USD | -213,416,000USD | -194,569,000USD | -133,233,000USD |
| Ebit | — | -441,619,000USD | -352,956,000USD | -293,778,000USD | -247,787,000USD | -213,416,000USD | -195,322,000USD | -133,233,000USD |
| Ebitda | — | -437,084,000USD | -348,254,000USD | -289,440,000USD | -243,985,000USD | -209,700,000USD | -191,935,000USD | -130,436,000USD |
| Depreciation And Amortization | — | 4,535,000USD | 4,702,000USD | 4,338,000USD | 3,802,000USD | 3,716,000USD | 3,387,000USD | 2,797,000USD |
| Reconciled Depreciation | — | 4,535,000USD | 4,702,000USD | 4,338,000USD | 3,802,000USD | 3,716,000USD | 3,387,000USD | 2,797,000USD |
| Total Other Income Expense Net | — | -8,594,000USD | -3,266,000USD | 10,063,000USD | 16,927,000USD | 27,344,000USD | 20,988,000USD | 23,410,000USD |
| Income Tax Expense | — | — | — | — | — | — | -753,000USD | — |
| Tax Provision | — | — | — | — | — | — | -753,000USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 888,000USD |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 11,580,000USD | 35,380,000USD | 42,983,000USD | 50,041,000USD | 0USD |
| Cost Of Revenue | 16,558,000USD | 592,225,000USD | 411,244,000USD | 253,073,000USD | 132,252,000USD | 91,755,000USD | 26,586,000USD |
| Gross Profit | -16,558,000USD | -592,225,000USD | 11,580,000USD | 35,380,000USD | 42,983,000USD | 50,041,000USD | -26,586,000USD |
| Research Development | 978,682,000USD | 592,225,000USD | 423,144,000USD | 253,073,000USD | 132,252,000USD | 91,755,000USD | 26,586,000USD |
| Selling General Administrative | 187,129,000USD | 97,299,000USD | 75,621,000USD | 40,586,000USD | 21,428,000USD | 12,406,000USD | 4,543,000USD |
| Total Operating Expenses | 1,165,811,000USD | 689,524,000USD | 498,765,000USD | 293,659,000USD | 153,680,000USD | 104,161,000USD | 4,543,000USD |
| Operating Income | -1,182,369,000USD | -689,524,000USD | -487,185,000USD | -258,279,000USD | -110,697,000USD | -54,120,000USD | -31,129,000USD |
| Interest Income | 90,694,000USD | 86,883,000USD | 47,482,000USD | 9,154,000USD | 2,238,000USD | 2,189,000USD | 105,000USD |
| Interest Expense | 24,231,000USD | 0USD | 303,000USD | 9,656,000USD | 71,000USD | 106,000USD | 103,000USD |
| Net Interest Income | 66,463,000USD | 86,883,000USD | 47,179,000USD | 9,154,000USD | 2,167,000USD | 2,083,000USD | 2,000USD |
| Income Before Tax | -1,131,301,000USD | -600,846,000USD | -439,891,000USD | -249,125,000USD | -108,530,000USD | -52,037,000USD | -31,127,000USD |
| Tax Provision | 0USD | -753,000USD | -3,524,000USD | -420,000USD | -371,000USD | -4,373,000USD | 0USD |
| Net Income | -1,131,301,000USD | -600,093,000USD | -436,367,000USD | -248,705,000USD | -108,159,000USD | -47,664,000USD | -31,127,000USD |
| Net Income From Continuing Ops | -1,131,301,000USD | -600,093,000USD | -436,367,000USD | -248,705,000USD | -108,159,000USD | -47,664,000USD | -31,127,000USD |
| Ebit | -1,107,070,000USD | -600,846,000USD | -439,588,000USD | -249,125,000USD | -108,459,000USD | -51,931,000USD | -31,024,000USD |
| Ebitda | -1,090,512,000USD | -589,022,000USD | -430,279,000USD | -239,469,000USD | -101,914,000USD | -48,589,000USD | -29,836,000USD |
| Depreciation And Amortization | 16,558,000USD | 11,824,000USD | 9,309,000USD | 9,656,000USD | 6,545,000USD | 3,342,000USD | 1,188,000USD |
| Reconciled Depreciation | 16,558,000USD | 11,824,000USD | 9,309,000USD | 9,656,000USD | 6,545,000USD | 3,342,000USD | 1,188,000USD |
| Total Other Income Expense Net | 51,068,000USD | 88,678,000USD | 47,294,000USD | 9,154,000USD | 2,167,000USD | 2,083,000USD | 2,000USD |
| Income Tax Expense | — | -753,000USD | -3,524,000USD | -420,000USD | -371,000USD | -4,373,000USD | 105,000USD |
| Selling And Marketing Expenses | — | — | 3,199,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -248,705,000USD | -110,378,000USD | -61,902,000USD | -34,890,000USD |
| Non Operating Income Net Other | — | — | — | — | 2,238,000USD | — | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | -26,586,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,323,270,000USD | 2,253,737,000USD | 2,354,508,000USD | 2,251,920,000USD | 2,429,568,000USD | 2,365,353,000USD | 2,558,301,000USD | 1,762,999,000USD |
| Cash And Equivalents | 815,435,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 3,937,969,000USD | 1,908,084,000USD | 2,025,679,000USD | 1,931,508,000USD | 2,137,171,000USD | 2,102,675,000USD | 2,289,299,000USD | 1,549,481,000USD |
| Short Term Investments | 3,122,534,000USD | 1,467,145,000USD | 1,641,934,000USD | 1,714,066,000USD | 1,734,733,000USD | 1,769,121,000USD | 1,746,235,000USD | 1,348,219,000USD |
| Total Current Assets | 4,028,338,000USD | 1,967,913,000USD | 2,075,037,000USD | 1,977,489,000USD | 2,176,439,000USD | 2,134,582,000USD | 2,327,632,000USD | 1,579,139,000USD |
| Other Current Assets | 90,369,000USD | 59,829,000USD | 49,358,000USD | 45,981,000USD | 39,268,000USD | 31,907,000USD | 38,333,000USD | 29,658,000USD |
| Other Non Current Assets | 14,760,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,717,032,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 354,061,000USD | 289,599,000USD | 290,424,000USD | 245,622,000USD | 184,534,000USD | 158,599,000USD | 163,914,000USD | 110,863,000USD |
| Other Current Liabilities | 5,145,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 1,648,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 2,606,238,000USD | 1,499,917,000USD | 1,631,297,000USD | 1,596,904,000USD | 1,865,369,000USD | 2,078,150,000USD | 2,265,204,000USD | 1,566,304,000USD |
| Total Equity Including Noncontrolling Interest | 2,606,238,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 162,452,000USD | 161,370,000USD | 165,278,000USD | 167,376,000USD | 147,049,000USD | 142,930,000USD | 141,823,000USD | 99,152,000USD |
| Goodwill | 14,608,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 55,800,000USD | 55,800,000USD | 55,800,000USD | 55,869,000USD | 56,136,000USD | 56,403,000USD | 56,670,000USD | 56,937,000USD |
| Accounts Payable | 88,419,000USD | 80,538,000USD | 64,616,000USD | 74,849,000USD | 56,761,000USD | 47,507,000USD | 54,427,000USD | 24,456,000USD |
| Short Term Debt | 16,753,000USD | 16,610,000USD | 16,468,000USD | 16,326,000USD | 13,088,000USD | 12,979,000USD | 12,872,000USD | 8,396,000USD |
| Common Stock | 21,000USD | 19,000USD | 19,000USD | 18,000USD | 18,000USD | 18,000USD | 18,000USD | 16,000USD |
| Retained Earnings | -3,967,289,000USD | -3,322,918,000USD | -2,869,102,000USD | -2,504,210,000USD | -2,199,004,000USD | -1,951,217,000USD | -1,737,801,000USD | -1,543,232,000USD |
| Accumulated Other Comprehensive Income | -5,950,000USD | -622,000USD | 3,237,000USD | 3,116,000USD | 1,302,000USD | 1,707,000USD | 1,321,000USD | 3,812,000USD |
| Total Liab | — | 753,820,000USD | 723,211,000USD | 655,016,000USD | 564,199,000USD | 287,203,000USD | 293,097,000USD | 196,695,000USD |
| Other Current Liab | — | 192,451,000USD | 209,340,000USD | 154,447,000USD | 114,685,000USD | 98,113,000USD | 96,615,000USD | 78,011,000USD |
| Capital Stock | — | 19,000USD | 19,000USD | 18,000USD | 18,000USD | 18,000USD | 18,000USD | 16,000USD |
| Good Will | — | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD |
| Cash | — | 440,939,000USD | 383,745,000USD | 217,442,000USD | 402,438,000USD | 333,554,000USD | 543,064,000USD | 201,262,000USD |
| Net Debt | — | -3,667,000USD | -225,043,000USD | -58,981,000USD | -269,651,000USD | -199,212,000USD | -407,221,000USD | -114,556,000USD |
| Short Long Term Debt Total | — | 437,272,000USD | 158,702,000USD | 158,461,000USD | 132,787,000USD | 134,342,000USD | 135,843,000USD | 86,706,000USD |
| Property Plant Equipment Gross | — | 192,051,000USD | 193,791,000USD | 194,390,000USD | 172,077,000USD | 166,311,000USD | 163,646,000USD | 120,825,000USD |
| Common Stock Shares Outstanding | — | 198,098,047shares | 190,129,154shares | 189,231,000shares | 188,145,904shares | 188,146,000shares | 167,737,672shares | 166,843,984shares |
| Non Current Assets Total | — | 285,824,000USD | 279,471,000USD | 274,431,000USD | 253,129,000USD | 230,771,000USD | 230,669,000USD | 183,860,000USD |
| Non Current Liabilities Total | — | 464,221,000USD | 432,787,000USD | 409,394,000USD | 379,665,000USD | 128,604,000USD | 129,183,000USD | 85,832,000USD |
| Non Current Liabilities Other | — | 287,522,000USD | 269,654,000USD | 258,988,000USD | 252,285,000USD | 4,138,000USD | 670,000USD | 1,644,000USD |
| Non Currrent Assets Other | — | 54,046,000USD | 43,785,000USD | 36,578,000USD | 35,336,000USD | 16,830,000USD | 17,568,000USD | 13,163,000USD |
| Net Working Capital | — | 1,678,314,000USD | 1,784,613,000USD | 1,731,867,000USD | 1,991,905,000USD | 1,975,983,000USD | 2,163,718,000USD | 1,468,276,000USD |
| Unclassified Non Current Liabilities | — | 176,699,000USD | 163,133,000USD | 150,406,000USD | 127,380,000USD | 124,466,000USD | 128,513,000USD | 84,188,000USD |
| Unclassified Equity | — | 4,823,419,000USD | 4,497,124,000USD | 4,097,962,000USD | 4,063,035,000USD | 4,027,624,000USD | 4,001,648,000USD | 3,105,692,000USD |
| Net Receivables | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,354,508,000USD | 2,558,301,000USD | 2,061,705,000USD | 811,930,000USD | 737,988,000USD | 567,401,000USD | 220,529,000USD | 170,586,000USD |
| Intangible Assets | 55,800,000USD | 56,670,000USD | 57,739,000USD | 58,807,000USD | 59,876,000USD | 60,945,000USD | 62,013,000USD | 63,082,000USD |
| Other Current Assets | 49,358,000USD | 38,333,000USD | 25,072,000USD | 10,569,000USD | 6,790,000USD | 6,988,000USD | 2,486,000USD | 1,945,000USD |
| Total Liab | 723,211,000USD | 293,097,000USD | 235,511,000USD | 126,742,000USD | 135,420,000USD | 92,725,000USD | 67,994,000USD | 73,927,000USD |
| Total Stockholder Equity | 1,631,297,000USD | 2,265,204,000USD | 1,826,194,000USD | 685,188,000USD | 602,568,000USD | 474,676,000USD | 152,535,000USD | 96,659,000USD |
| Other Current Liab | 209,340,000USD | 96,615,000USD | 74,694,000USD | 29,446,000USD | 27,721,000USD | 18,784,000USD | 14,528,000USD | 8,339,000USD |
| Common Stock | 19,000USD | 18,000USD | 16,000USD | 9,000USD | 8,000USD | 7,000USD | — | 3,000USD |
| Capital Stock | 19,000USD | 18,000USD | 16,000USD | 9,000USD | 8,000USD | 7,000USD | 305,109,000USD | 3,000USD |
| Retained Earnings | -2,869,102,000USD | -1,737,801,000USD | -1,137,708,000USD | -701,341,000USD | -452,636,000USD | -265,545,000USD | -157,386,000USD | -109,722,000USD |
| Good Will | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD | 14,608,000USD |
| Cash | 383,745,000USD | 543,064,000USD | 696,148,000USD | 161,412,000USD | 108,497,000USD | 104,268,000USD | 16,659,000USD | 69,586,000USD |
| Cash And Short Term Investments | 2,025,679,000USD | 2,289,299,000USD | 1,852,955,000USD | 644,943,000USD | 577,054,000USD | 440,741,000USD | 122,758,000USD | 69,586,000USD |
| Total Current Assets | 2,075,037,000USD | 2,327,632,000USD | 1,879,281,000USD | 660,185,000USD | 589,773,000USD | 454,122,000USD | 133,981,000USD | 85,431,000USD |
| Total Current Liabilities | 290,424,000USD | 163,914,000USD | 143,851,000USD | 61,984,000USD | 60,350,000USD | 47,176,000USD | 43,052,000USD | 30,552,000USD |
| Net Debt | -225,043,000USD | -407,221,000USD | -608,204,000USD | -97,207,000USD | -41,864,000USD | -71,604,000USD | -16,659,000USD | -69,439,000USD |
| Short Term Debt | 16,468,000USD | 12,872,000USD | 7,369,000USD | 6,773,000USD | 6,214,000USD | 3,672,000USD | 200,000USD | 147,000USD |
| Short Long Term Debt Total | 158,702,000USD | 135,843,000USD | 87,944,000USD | 64,205,000USD | 66,633,000USD | 32,664,000USD | 172,000USD | 318,000USD |
| Short Term Investments | 1,641,934,000USD | 1,746,235,000USD | 1,156,807,000USD | 483,531,000USD | 468,557,000USD | 336,473,000USD | 106,099,000USD | — |
| Accounts Payable | 64,616,000USD | 54,427,000USD | 61,788,000USD | 21,306,000USD | 14,057,000USD | 12,609,000USD | 11,400,000USD | 5,236,000USD |
| Property Plant Equipment Net | 165,278,000USD | 141,823,000USD | 100,014,000USD | 73,736,000USD | 71,236,000USD | 36,337,000USD | 7,147,000USD | 6,872,000USD |
| Property Plant Equipment Gross | 193,791,000USD | 163,646,000USD | 117,708,000USD | 88,225,000USD | 82,048,000USD | 36,337,000USD | 7,147,000USD | 6,872,000USD |
| Accumulated Other Comprehensive Income | 3,237,000USD | 1,321,000USD | 544,000USD | -1,780,000USD | -376,000USD | 116,000USD | 74,000USD | -3,623,000USD |
| Common Stock Shares Outstanding | 190,129,154shares | 167,737,672shares | 113,149,869shares | 80,626,525shares | 72,806,079shares | 66,599,748shares | 36,473,121shares | 36,473,121shares |
| Non Current Assets Total | 279,471,000USD | 230,669,000USD | 182,424,000USD | 151,745,000USD | 148,215,000USD | 113,279,000USD | 86,548,000USD | 85,155,000USD |
| Non Current Liabilities Total | 432,787,000USD | 129,183,000USD | 91,660,000USD | 64,758,000USD | 75,070,000USD | 45,549,000USD | 24,942,000USD | 43,375,000USD |
| Non Current Liabilities Other | 269,654,000USD | 670,000USD | 1,458,000USD | 301,000USD | 634,000USD | 38,105,000USD | 655,000USD | 516,000USD |
| Non Currrent Assets Other | 43,785,000USD | 17,568,000USD | 10,063,000USD | 4,594,000USD | 2,495,000USD | 1,389,000USD | 2,780,000USD | 593,000USD |
| Net Working Capital | 1,784,613,000USD | 2,163,718,000USD | 1,735,430,000USD | 598,201,000USD | 558,123,000USD | 406,946,000USD | 90,929,000USD | 54,879,000USD |
| Unclassified Non Current Liabilities | 163,133,000USD | 128,513,000USD | 90,202,000USD | 56,531,000USD | 59,285,000USD | -16,557,000USD | -2,755,000USD | — |
| Unclassified Equity | 4,497,124,000USD | 4,001,648,000USD | 2,963,326,000USD | 1,388,291,000USD | 1,055,564,000USD | 740,091,000USD | 4,738,000USD | 209,998,000USD |
| Net Receivables | — | 0USD | 1,254,000USD | 4,673,000USD | 5,929,000USD | 6,393,000USD | 8,737,000USD | 7,303,000USD |
| Other Assets | — | — | 1USD | 4,594,000USD | 2,495,000USD | 1,389,000USD | 2,780,000USD | 593,000USD |
| Current Deferred Revenue | — | — | -54,554,000USD | 4,459,000USD | 12,358,000USD | 12,111,000USD | 17,124,000USD | 16,830,000USD |
| Inventory | — | — | 1USD | 1USD | -12,719,000USD | — | 1USD | 6,597,000USD |
| Deferred Long Term Liab | — | — | — | 600,000USD | 500,000USD | 7,444,000USD | 2,100,000USD | — |
| Other Liab | — | — | — | 7,326,000USD | 14,651,000USD | 16,557,000USD | 24,942,000USD | 43,375,000USD |
| Net Tangible Assets | — | — | — | 611,773,000USD | 528,084,000USD | 399,123,000USD | -229,195,000USD | -186,112,000USD |
| Unclassified Non Current Assets | — | — | — | -4,594,000USD | -2,495,000USD | -1,389,000USD | -2,780,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 4,300,000USD |
| Stock Based Compensation | 154,299,000USD |
| Change To Liabilities | 61,372,000USD |
| Change In Working Capital | -19,123,000USD |
| Operating Cash Flow | -741,484,000USD |
| Capital Expenditures | -3,824,000USD |
| Net Investments | -2,248,094,000USD |
| Unclassified Investing Cash Flow | 765,863,000USD |
| Investing Cash Flow | -1,486,055,000USD |
| Common Stock Issuance | 41,053,000USD |
| Unclassified Financing Cash Flow | 2,618,176,000USD |
| Financing Cash Flow | 2,659,229,000USD |
| Change In Cash | 431,690,000USD |
| End Cash Flow | 820,293,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -453,816,000USD | -364,892,000USD | -305,206,000USD | -247,787,000USD | -213,416,000USD | -194,569,000USD | -156,288,000USD | -133,233,000USD |
| Depreciation | 4,535,000USD | 33,325,000USD | 4,338,000USD | 3,802,000USD | 3,716,000USD | 3,387,000USD | 66,000USD | 2,797,000USD |
| Stock Based Compensation | 87,299,000USD | 33,696,000USD | 30,779,000USD | 28,830,000USD | 25,084,000USD | 22,439,000USD | 20,775,000USD | 19,775,000USD |
| Other Non Cash Items | 24,762,000USD | -8,613,000USD | 6,335,000USD | -2,299,000USD | -12,256,000USD | -11,567,000USD | -8,099,000USD | -12,766,000USD |
| Change In Working Capital | -16,945,000USD | 32,246,000USD | 56,443,000USD | -4,303,000USD | 2,437,000USD | 42,782,000USD | 13,127,000USD | -4,740,000USD |
| Total Cash From Operating Activities | -354,165,000USD | -274,238,000USD | -207,311,000USD | -221,757,000USD | -194,435,000USD | -138,290,000USD | -130,419,000USD | -128,167,000USD |
| Capital Expenditures | -1,538,000USD | -1,925,000USD | -3,349,000USD | -7,450,000USD | -3,266,000USD | -1,222,000USD | -3,520,000USD | -2,399,000USD |
| Free Cash Flow | -355,703,000USD | -276,163,000USD | -210,660,000USD | -229,207,000USD | -197,701,000USD | -139,512,000USD | -133,939,000USD | -130,566,000USD |
| Investments | 174,153,000USD | 76,807,000USD | 24,849,000USD | 34,276,000USD | -15,949,000USD | -392,903,000USD | -21,469,000USD | 107,944,000USD |
| Total Cashflows From Investing Activities | 172,615,000USD | 74,882,000USD | 24,849,000USD | 34,276,000USD | -15,949,000USD | -392,903,000USD | -21,469,000USD | 107,944,000USD |
| Total Cash From Financing Activities | 238,744,000USD | 365,659,000USD | -1,592,000USD | 256,583,000USD | 874,000USD | 873,805,000USD | 77,294,000USD | 7,504,000USD |
| Issuance Of Capital Stock | 226,730,000USD | 347,915,000USD | — | — | 0USD | 772,055,000USD | 74,293,000USD | 0USD |
| Change In Cash | 57,194,000USD | 166,303,000USD | -184,054,000USD | 69,102,000USD | -209,510,000USD | 341,802,000USD | -74,594,000USD | -12,719,000USD |
| Begin Period Cash Flow | 383,745,000USD | 222,300,000USD | 406,354,000USD | 337,252,000USD | 546,762,000USD | 201,262,000USD | 278,744,000USD | 288,432,000USD |
| End Period Cash Flow | 440,939,000USD | 388,603,000USD | 222,300,000USD | 406,354,000USD | 337,252,000USD | 543,064,000USD | 204,150,000USD | 275,713,000USD |
| Other Cashflows From Financing Activities | -252,000USD | -244,024,000USD | -5,740,000USD | 250,002,000USD | -18,000USD | 284,000USD | 3,001,000USD | 7,504,000USD |
| Unclassified Financing Cash Flow | 12,266,000USD | 610,935,000USD | 4,148,000USD | — | — | 871,656,000USD | — | -3,164,000USD |
| Change To Account Receivables | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | -1,252,000USD | — | 4,644,000USD | — | 1,865,000USD | — | 3,164,000USD |
| Other Cashflows From Investing Activities | — | — | 28,198,000USD | — | — | — | — | 110,343,000USD |
| Unclassified Investing Cash Flow | — | — | -24,849,000USD | 7,450,000USD | 3,266,000USD | — | 3,520,000USD | -107,944,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,131,301,000USD | -600,093,000USD | -436,367,000USD | -248,705,000USD | -187,091,000USD | -108,159,000USD | -47,664,000USD | -41,789,000USD |
| Depreciation | -26,961,000USD | 11,824,000USD | 9,309,000USD | 9,656,000USD | 7,332,000USD | 6,545,000USD | 3,342,000USD | 1,764,000USD |
| Stock Based Compensation | 118,389,000USD | 79,197,000USD | 61,772,000USD | 31,196,000USD | 20,724,000USD | 8,886,000USD | 3,161,000USD | 855,000USD |
| Other Non Cash Items | 55,309,000USD | -48,770,000USD | -22,038,000USD | -2,640,000USD | 3,131,000USD | 1,343,000USD | 373,000USD | 2,121,000USD |
| Change To Account Receivables | 0USD | 1,254,000USD | 3,419,000USD | 1,256,000USD | 464,000USD | 2,344,000USD | -1,434,000USD | -7,303,000USD |
| Change In Working Capital | 86,823,000USD | 1,168,000USD | 40,662,000USD | -13,489,000USD | 8,724,000USD | -8,304,000USD | -4,455,000USD | 38,061,000USD |
| Total Cash From Operating Activities | -897,741,000USD | -557,436,000USD | -350,572,000USD | -224,401,000USD | -147,180,000USD | -100,064,000USD | -49,616,000USD | 1,213,000USD |
| Capital Expenditures | -15,990,000USD | -10,308,000USD | -7,729,000USD | -10,816,000USD | -6,528,000USD | -2,933,000USD | -2,589,000USD | -1,499,000USD |
| Free Cash Flow | -913,731,000USD | -567,744,000USD | -358,301,000USD | -235,217,000USD | -153,708,000USD | -102,997,000USD | -52,205,000USD | -286,000USD |
| Investments | 134,048,000USD | -554,394,000USD | -342,598,000USD | -24,116,000USD | -135,589,000USD | -231,300,000USD | -105,576,000USD | -1,339,000USD |
| Total Cashflows From Investing Activities | 118,058,000USD | -554,394,000USD | -342,598,000USD | -24,116,000USD | -142,117,000USD | -234,233,000USD | -101,969,000USD | -1,339,000USD |
| Total Cash From Financing Activities | 621,524,000USD | 959,413,000USD | 1,229,200,000USD | 301,432,000USD | 294,179,000USD | 422,776,000USD | 98,658,000USD | 60,847,000USD |
| Sale Purchase Of Stock | 8,036,000USD | 5,029,000USD | 3,317,000USD | 1,864,000USD | 1,875,000USD | 832,000USD | -45,000USD | -131,000USD |
| Issuance Of Capital Stock | 347,915,000USD | 846,348,000USD | 385,759,000USD | 298,045,000USD | 291,241,000USD | 420,067,000USD | 100,028,000USD | 60,558,000USD |
| Change In Cash | -158,159,000USD | -153,084,000USD | 534,736,000USD | 52,915,000USD | 4,882,000USD | 88,479,000USD | -52,927,001USD | 60,721,000USD |
| Begin Period Cash Flow | 546,762,000USD | 696,148,000USD | 161,412,000USD | 110,234,000USD | 105,352,000USD | 16,873,000USD | 69,586,000USD | 9,079,000USD |
| End Period Cash Flow | 388,603,000USD | 543,064,000USD | 696,148,000USD | 163,149,000USD | 110,234,000USD | 105,352,000USD | 16,658,999USD | 69,800,000USD |
| Other Cashflows From Financing Activities | 220,000USD | 284,000USD | 836,808,000USD | 3,387,000USD | 2,938,000USD | 2,709,000USD | 98,658,000USD | 60,847,000USD |
| Unclassified Financing Cash Flow | 613,268,000USD | 954,100,000USD | 389,075,000USD | 296,181,000USD | 289,366,000USD | 419,235,000USD | — | — |
| Unclassified Investing Cash Flow | — | 10,308,000USD | 7,729,001USD | 24,116,000USD | 135,589,000USD | 231,300,000USD | — | 1,339,000USD |
| Other Cashflows From Investing Activities | — | — | -1USD | -13,300,000USD | -135,589,000USD | -231,300,000USD | 6,000,000USD | 160,000USD |
| Unclassified Operating Cash Flow | — | — | -3,910,000USD | — | — | — | -4,373,000USD | — |
| Change To Liabilities | — | — | — | -7,603,000USD | 578,000USD | -5,923,000USD | -12,501,000USD | 44,608,000USD |
| Change To Inventory | — | — | — | — | 7,682,000USD | -2,344,000USD | 1,434,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | 4,882,000USD | 88,479,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenue Related Party | 19,420,000 | USD | 0001564590-21-010276 |
| FY 2018Yearly · 2018-12-31 | Product | Collaboration Revenues Other | 745,000 | USD | 0001564590-21-010276 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.